BRIEF-NuVasive receives FDA 510(k)clearance

* Receives FDA 510(k) clearance reinforcing comprehensive

portfolio supporting pediatric, adolescent and adult spinal

deformity patients

Source text for Eikon:

Further company coverage:

Read more